D-0721-2026 Class II Ongoing

Recalled by Rohto-Mentholatum (Vietnam) Co., Ltd. — Ho Chi Minh, N/A

FDA drug recall D-0721-2026 was initiated by Rohto-Mentholatum (Vietnam) Co., Ltd. on Jul 14, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 353 cartons.

Recall details

Product Type
Drugs
Report Date
Jul 29, 2026
Initiation Date
Jul 14, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
353 cartons

Product description

Rohto Cooling Eye Drops Dry Aid (povidone 0.68%, propylene glycol 0.3%), Sterile, TWIN PACK 0.34 FL OZ (10 mL) each, Distributed by: The Mentholatum Company, Orchard Park, NY 14127, Made in Vietnam, UPC 310742011159, NDC 10742-8162-2

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

Nationwide within the United States

Code information

Lot #: 4G1V, Exp 2027/06; 4J1V, 512VB 2027/09; 5D1V, 2028/03; 5G1V, 512VB 2028/06; 512V, 512VB 2028/08

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0721-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0721-2026. Report a data issue: hello@regdatalab.com.